ICU Medical (NASDAQ:ICUI) Stock Price Down 6% on Insider Selling

ICU Medical, Inc. (NASDAQ:ICUI) shares were down 6% during mid-day trading on Tuesday after an insider sold shares in the company. The stock traded as low as $156.95 and last traded at $157.78. Approximately 155,950 shares changed hands during mid-day trading, a decline of 43% from the average daily volume of 273,648 shares. The stock had previously closed at $167.81.

Specifically, COO Christian B. Voigtlander sold 1,962 shares of the company’s stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $169.08, for a total transaction of $331,734.96. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Analyst Ratings Changes

ICUI has been the topic of several recent research reports. Needham & Company LLC reissued a “hold” rating on shares of ICU Medical in a research note on Wednesday, November 13th. KeyCorp boosted their price target on ICU Medical from $198.00 to $209.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 13th. StockNews.com raised ICU Medical from a “hold” rating to a “buy” rating in a research note on Wednesday, November 20th. Raymond James boosted their target price on ICU Medical from $158.00 to $190.00 and gave the stock an “outperform” rating in a research report on Thursday, September 12th. Finally, Jefferies Financial Group initiated coverage on ICU Medical in a report on Monday, October 14th. They issued a “hold” rating and a $183.00 target price on the stock. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, ICU Medical presently has a consensus rating of “Moderate Buy” and a consensus target price of $173.00.

ICU Medical Trading Up 1.3 %

The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29. The business has a fifty day simple moving average of $175.61 and a 200 day simple moving average of $146.51. The stock has a market cap of $3.91 billion, a price-to-earnings ratio of -34.96 and a beta of 0.66.

Institutional Trading of ICU Medical

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Victory Capital Management Inc. lifted its holdings in ICU Medical by 2,966.3% in the 2nd quarter. Victory Capital Management Inc. now owns 141,848 shares of the medical instruments supplier’s stock valued at $16,844,000 after purchasing an additional 137,222 shares in the last quarter. Millennium Management LLC lifted its stake in shares of ICU Medical by 327.8% during the second quarter. Millennium Management LLC now owns 136,070 shares of the medical instruments supplier’s stock valued at $16,158,000 after buying an additional 104,264 shares during the period. FMR LLC lifted its stake in shares of ICU Medical by 2,676.6% during the third quarter. FMR LLC now owns 104,094 shares of the medical instruments supplier’s stock valued at $18,968,000 after buying an additional 100,345 shares during the period. Granite Investment Partners LLC acquired a new stake in ICU Medical during the second quarter worth approximately $10,650,000. Finally, F M Investments LLC purchased a new stake in ICU Medical in the 2nd quarter worth approximately $10,175,000. 96.10% of the stock is currently owned by hedge funds and other institutional investors.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.